The report entitled; “Needle-Free Drug Injection Systems Market, Trends, Dynamics, and Market Analysis,” recently published by Stratview Research offers a comprehensive outlook of the industry. This report by Type (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Application (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical, and Biotechnology companies, Other), and Region - COVID-19 Impact Analysis and Forecast to 2026.
According to the report, The Needle-Free Drug Injection Systems Market is projected to grow from USD 19.6 billion in 2020 to USD 44.8 billion by 2026 at a CAGR of around 14.8% during the forecast period.
Wish to know more about the study? Click here to get a free sample.
What's in the free sample report?
• Market Size & Share Analysis
• Key Players with Sales, Revenue, and Business Strategies Analysis
• Market Growth Drivers and Restraints
• Market Opportunities & Challenges
• Research Methodology
What queries are covered in this report–
l What are the key trends in the Needle-Free Drug Injection Systems Market?
l How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
l What is the impact of COVID-19 on the Needle-Free Drug Injection Systems Market?
l What are the key strategies adopted by the major vendors to lead in the market?
l What is the market share of the top vendors?
Major linchpins mentioned in the report are -
The market for Needle-Free Drug Injection Systems is gradually consolidating with major companies that are performing mergers & acquisitions to quickly gain the leading position and to tap the growing opportunities in this briskly expanding market. Some of the major key players in the Market are listed below.
- Antares Pharma, Inc. (US)
- Endo International plc (US)
- PharmaJet (U.S)
- Bioject Medical Technologies Inc. (U.S)
- Medical International Technology, Inc. (U.S)
- INJEX Pharma AG (Germany)
- National Medical Products Inc. (US)
- Valeritas, Inc. (US)
- European Pharma Group (Netherland)
- PenJet Corporation (U.S)
- Crossject SA (France)
Market Segmentation:
By application, the needle-free drug injection systems market has been bifurcated into hospitals and clinics, home care settings, research laboratories, pharmaceutical, and biotechnology companies, and others. Under these, the hospitals & clinics segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established infrastructure and skilled healthcare professionals.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the high demand for advanced drug delivery systems coupled with the presence of key market players such as Antares Pharma, Inc. (US) and Endo International plc (US). The market growth in the Asia-Pacific region is expected to be driven by increasing spending on healthcare.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing & procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com
What we do-
Stratview Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients existing globally. We at Stratview Research are obliged to serve our diverse customer base present across the industries of Aerospace, Oil and Gas, Automotive, and Chemicals, etc. among various other industries present around the world. We strive to provide our customers with updated information on ground-breaking technologies, high growing markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
